Approved by the Zhejiang Provincial People’s Government, sponsored by the Zhejiang Provincial Health Commission and undertaken by the Zhejiang Provincial Medical and Health International Cooperation and Development Center"2019 ZIMEX 16th Zhejiang Primary Medical Equipment Exhibition"Will beAugust 29 to August 31, 2019inHangzhou International Expo CenterHeld.

The purpose of the conference is to introduce advanced technology at home and abroad, display the latest medical equipment, in order to strengthen international technology and information exchange, expand external development, prosper the medical market in our province, and promote the accelerated development of our province's medical and health undertakings. Various forms of medical technology, information lectures and seminars were also held during the exhibition, which is a microcosm of the development of the medical and health industry in our province, and will also play a role as a weather vane.

Ningbo Aocheng Biotechnology Co., Ltd. is a high-tech biological enterprise focusing on the early detection, diagnosis, prevention and monitoring of diseases. By providing reliable, fast and convenient in vitro diagnostic products, it can provide accurate test results for diagnosis and treatment. At present, the company’s biomedical team continues to conduct in-depth exploration and prospective research in the field of high-risk diseases for pregnant women such as hypertension. We willCommitted to providing professional maternal and child health clinical diagnosis solutions.

During the exhibition, Ningbo Aocheng will bring its latest product-Placental Growth Factor (PlGF) testing reagents to the exhibition.

The new test product approved by Ningbo Aocheng Biotechnology Co., Ltd.-Placental Growth Factor (PlGF) Test Kit (Immunofluorescence Method)-was issued by the International Federation of Obstetrics and Gynecology (FIGO) on June 18, 2019. The strongest level recommendation in the Practical Guidelines for Preeclampsia Screening and Prevention has opened a new era of scientific and standardized management of hypertension and preeclampsia during pregnancy in my country.

The Aucheer iRate PlGF test reagent can help clinicians more reasonably carry out risk stratification and clinical assessment of high-risk factors and pregnant women with suspected preeclampsia, strengthen the management of preeclampsia, reduce or delay the occurrence and development of preeclampsia, and ensure the safety of mothers and fetuses.

Methodology:Time-resolved immunofluorescence

Linear range：12-3000pg/mL

Specimen type：Serum, plasma or whole blood

Accuracy：CV≤15%

Detection time：12min

Can be connected to the LIS system in the hospital